| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director | VP, Corporate Development
4 companies
Barthelemy Nicolas is a Director at STANDARD BIOTOOLS INC. with holdings across 4 companies. Recent SEC Form 4 filings include 1 buy and 3 sells.
Estimated insider holdings value: $2.0M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Feb 13, 2020 | LAB Standard Biotools Inc. | Director | Buy | 12,257 | $3.64 | $44,614.25 | +21.5% | |
| Jun 17, 2019 | LAB Standard Biotools Inc. | Director | Sell | 5,100 | $12.43 | $63,397.59 | -10.9% | |
| Aug 29, 2018 | RGEN Repligen Corp | Director | Sale+OE | 6,580 | $54.44 | $358,196.12 | -61.1% | |
| May 9, 2018 | RGEN Repligen Corp | Director | Sale+OE | 26,500 | $40.54 | $1,074,238.45 | -84.5% |